WallStreetZenWallStreetZen

NASDAQ: HUMA
Humacyte Inc Stock Ownership - Who owns Humacyte?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Humacyte Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Max N. WallaceDirector2023-11-216,564$1.19
$7.81kBuy
Brady W. DouganDirector2023-10-10114,420$1.19
$136.16kBuy
Laura E. NiklasonPresident CEO and Director2023-10-10114,420$1.19
$136.16kBuy
Brady W. DouganDirector2023-09-142,000,000$2.78
$5.56MSell
Laura E. NiklasonPresident CEO and Director2023-09-142,000,000$2.78
$5.56MSell
Laura E. NiklasonPresident CEO and Director2023-08-21602,443$3.39
$2.04MSell
Ayabudge LLC10% Owner2023-08-21602,443$3.39
$2.04MSell
Brady W. DouganDirector2023-08-21602,443$3.39
$2.04MSell
Laura E. NiklasonPresident CEO and Director2023-08-18626,979$3.57
$2.24MSell
Ayabudge LLC10% Owner2023-08-18626,979$3.57
$2.24MSell

1 of 3

HUMA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HUMA insiders and whales buy or sell their stock.

HUMA Shareholders

What type of owners hold Humacyte Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fresenius Medical Care Holdings Inc15.38%18,312,735$71.97MInsider
Ayabudge LLC6.88%8,191,140$32.19MInsider
Brady W. Dougan6.79%8,085,961$31.78MInsider
Laura E. Niklason6.79%8,085,961$31.78MInsider
Blackrock Inc4.11%4,899,289$19.25MInstitution
Vanguard Group Inc2.62%3,123,266$12.27MInstitution
Geode Capital Management LLC1.11%1,325,675$5.21MInstitution
Millennium Management LLC1.09%1,295,366$5.09MInstitution
State Street Corp0.97%1,152,791$4.53MInstitution
Prescott General Partners LLC0.48%568,246$2.23MInstitution

1 of 3

HUMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HUMA14.97%36.38%Net Selling
APLT57.95%8.47%Net SellingNet Selling
FULC64.02%35.98%Net BuyingNet Buying
SLRN73.07%26.93%Net BuyingNet Selling
THRD73.29%26.71%Net BuyingNet Buying
View Top Biotech Stocks

Humacyte Stock Ownership FAQ

Who owns Humacyte?

Humacyte (NASDAQ: HUMA) is owned by 14.97% institutional shareholders, 36.38% Humacyte insiders, and 48.66% retail investors. Fresenius Medical Care Holdings Inc is the largest individual Humacyte shareholder, owning 18.31M shares representing 15.38% of the company. Fresenius Medical Care Holdings Inc's Humacyte shares are currently valued at $69.95M.

If you're new to stock investing, here's how to buy Humacyte stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.